Salivary gland cancers are rare with an annual incidence of approximately 3.0 cases per
100,000 in the United States accounting for less than 3% of all head and neck cancers. They …

This is the official guideline endorsed by the specialty associations involved in the care of
head and neck cancer patients in the UK. Salivary gland tumours are rare and have very …

Objective (1) To identify predictors of nodal disease in parotid malignancies using various
clinical and pathologic variables.(2) To examine the effect of nodal disease on overall …

The purpose of this study was to suggest general guidelines in the management of the N0
neck of oral cavity and oropharyngeal adenoid cystic carcinoma (AdCC) in order to improve …

Purpose To report outcomes of postoperative radiotherapy (PORT) for major salivary gland
carcinoma (SGC) and identify patients at high risk of distant metastases (DM). Methods and …

Objective To define the incidence and pattern of spread of lymph node metastasis from
parotid cancers and to clarify the risk factors and appropriate extent of neck dissection (ND) …

The successful treatment of salivary gland malignancies originating in the parotid gland
begins with rigorous and thorough surgical management coupled with the directed and …

Background: Salivary gland tumors are an uncommon entity, comprising 3% to 6% of all
head and neck tumors. Approximately 75% to 80% occur in the parotid gland, and 80% are …

Metastases from salivary gland carcinomas to the cervical lymph nodes are relatively
uncommon. However, their impact on prognosis is significant and, thus, it is important to …

Salivary gland tumours represent a diverse range of tumours with many histological
subtypes which occur in major and minor salivary glands. The management of these …